A Pharmacokinetic Crushed-Tablet Bioavailability Study of Crushable Dose Formulation of Vibegron
Latest Information Update: 14 Nov 2019
At a glance
- Drugs Vibegron (Primary)
- Indications Overactive bladder; Pain
- Focus Pharmacokinetics
- Sponsors Urovant Sciences
Most Recent Events
- 14 Nov 2019 New trial record
- 05 Nov 2019 According to an Urovant Sciences media release, this study was conducted to support administration of vibegron as a crushed tablet.